PRPH
ProPhase Labs, Inc.
NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS
Rating:D+
Company Profile
CEO
Ted William Karkus
IPO Date
1994-04-04
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
ProPhase Labs, Inc.
CEO
Ted William Karkus
IPO Date
1994-04-04
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
| 500,000 |
| $0.60 |
| 18 Feb 2025 | GLECKEL LOUIS MD | director | A-Award | Acquired | 100,000 | $0.60 |
| 18 Feb 2025 | Hirsch Warren | director | A-Award | Acquired | 100,000 | $0.60 |
| 21 Mar 2024 | Karkus Ted William | director, 10 percent owner, officer: CEO & CHAIRMAN | A-Award | Acquired | 400,000 | $6.00 |
| 19 Mar 2024 | Barr Jason Michael | director | A-Award | Acquired | 70,000 | $6.00 |
| 19 Mar 2024 | Latkin Jed | director | A-Award | Acquired | 500,000 | $6.00 |
| 19 Mar 2024 | Latkin Jed | officer | Disposed | 0 | $0.00 |
| 19 Mar 2024 | Karkus Ted William | director, 10 percent owner, officer: CEO & CHAIRMAN | A-Award | Disposed | 400,000 | $6.00 |
| 19 Mar 2024 | GLECKEL LOUIS MD | director | A-Award | Acquired | 70,000 | $6.00 |